Finance
Biomaterials company reports increased third-quarter revenue: $16.5 million
Published in Medical Devices and Surgical Technology Week, December 4th, 2005
The net loss in the third quarter of 2005 was $3.1 million, or $0.14 per fully diluted common share, compared to a net loss of $6.0 million, or $0.26 per fully diluted common share in the third quarter of 2004.
Excluding a $412,000, or $0.02 per common share, noncash gain for the change in the value of the derivative related to the company's 6% convertible preferred stock and a $701,000, or $0.03 per common share, charge related to post...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Diagnostics
Modified flow cytometer detects infrared fluorescence - Medical Devices
Autotransfusion system reduces allogeneic blood use during endoluminal AAA repair - Medical Devices
Insignia I Ultra ventricular automatic capture is accurate and safe - Surgical Technology
Endoscopic membranectomy with a high-frequency-wave snare/cutter in upper GI tract effective - Surgical Technology
Stereotactic image guidance improves safety and efficiency of thoracoscopic discectomy - Adverse Drug Reaction
High-dose corticosteroid treatment reduces bone mineral density - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
